Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Celestica | CLS | Nov 5, 2024 | 75.63 | +4.58 |
Celldex Therapeutics | CLDX | Nov 5, 2024 | 25.43 | +0.16 |
Cellebrite | CLBT | Nov 5, 2024 | 19.15 | +3.23 |
Cellectar Biosciences | CLRB | Nov 5, 2024 | 2.03 | 0.00 |
Cellectis ADR | CLLS | Nov 5, 2024 | 1.78 | +1.14 |
Celsius | CELH | Nov 5, 2024 | 31.73 | +2.12 |
Celularity A | CELU | Nov 5, 2024 | 1.55 | 0.00 |
Cementos Pacasmayo ADR | CPAC | Nov 5, 2024 | 6.16 | -2.07 |
CEMEX ADR | CX | Nov 5, 2024 | 5.27 | +1.93 |
Cemtrex | CETX | Nov 5, 2024 | 0.21 | -5.51 |
Cencora | COR | Nov 5, 2024 | 233.99 | +0.04 |
Cenntro | CENN | Nov 5, 2024 | 1.27 | 0.00 |
Cenovus Energy | CVE | Nov 5, 2024 | 16.13 | -0.49 |
Centene | CNC | Nov 5, 2024 | 64.80 | +1.54 |
CenterPoint Energy | CNP | Nov 5, 2024 | 29.55 | +1.83 |
Centerra Gold | CGAU | Nov 5, 2024 | 6.36 | -0.16 |
Centerspace | CSR-C | Nov 5, 2024 | 24.98 | 0.00 |
Centessa Pharmaceuticals ADR | CNTA | Nov 5, 2024 | 16.00 | +0.69 |
Centrais Electricas Brasileiras B ADR | EBR-B | Nov 5, 2024 | 7.19 | +0.56 |
Centrais Eletricas Brasileiras ADR | EBR | Nov 5, 2024 | 6.51 | -0.15 |
Central Garden & Pet | CENT | Nov 5, 2024 | 36.32 | +3.27 |
Central Garden & Pet A | CENTA | Nov 5, 2024 | 31.07 | +3.46 |
Central Pacific Financial | CPF | Nov 5, 2024 | 27.43 | +2.08 |
Central Plains Bancshares | CPBI | Nov 5, 2024 | 14.10 | +0.71 |
Central Puerto ADR | CEPU | Nov 5, 2024 | 11.71 | +3.45 |
Central Securities | CET | Nov 5, 2024 | 47.13 | +0.71 |
Centrus Energy A | LEU | Nov 5, 2024 | 75.73 | -2.91 |
Centuri Holdings | CTRI | Nov 5, 2024 | 19.41 | +2.43 |
Centurion Acquisition | ALFUU | Nov 5, 2024 | 10.08 | 0.00 |
Century Aluminium | CENX | Nov 5, 2024 | 21.05 | +20.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.